Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs

Table 1 Neuropsychological battery and normative data by seven major neurocognitive domains

Neuropsychological Domain and Test	Normative Data Sources
Executive functioning
Wisconsin Card Sorting Task-64 Item	[29]^a,b
Trail Making Test (Part B)	[28]^a,b,c,d
Learning
Hopkins Verbal Learning Test—Revised	[26]^a
Brief Visuospatial Memory Test—Revised	[25]^a
Memory
Hopkins Verbal Learning Test—Revised	[26]^a
Brief Visuospatial Memory Test—Revised	[25]^a
Attention/Working Memory
WAIS-IV Letter Number Sequencing	[30]^a,b,c,d
PASAT-50 Total Correct	[27]^a,b,d
Speed of Information Processing
WAIS-IV Coding	[30]^a,b,c,d
WAIS-IV Symbol Search	[30]^a,b,c,d [28]^a,b,c,d
Trail Making Test (Part A)	[30]^a,b,c,d [28]^a,b,c,d
Motor Skills
Grooved Pegboard Time	[28]^b,c,d
Verbal Fluency
Controlled Oral Word Association Test (FAS)	[28]^a,b,c,d
Semantic (Animal) Fluency	[28]^a,b,c,d

Wechsler Adult Intelligence Scales (WAIS); Paced Auditory Serial Arithmetic Test (PASAT); Normative data corrects for the demographic characteristics indicated by superscript: ^aAge;^b Education; ^c Gender; ^dEthnicity